Clinical Trial Update: Study to Confirm the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating CJ-12420 for safety and efficacy in erosive esophagitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Esophagitis

Drugs mentioned

• CJ-12420

Snippet

Sponsor: HK inno.N Corporation | Conditions: Erosive Esophagitis | Phase 3 | Status: COMPLETED